ArticleJournal of surgical case reports2026
Mini OPCAB in severe COPD-world's first report of three cases.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic obstructive pulmonary disease (COPD) among patients requiring coronary artery bypass graft is common and is associated with worse outcomes. Although off pump coronary artery bypass (OPCAB) ameliorates cardiopulmonary bypass related derangements, COPD is still an independent risk factor for adverse outcomes. As minimally invasive direct coronary artery bypass is an absolute contraindication in COPD, an alternative minimally invasive approach is imperative to optimize outcomes. We present the world's first reported cases in the literature of Mini OPCAB performed successfully in three patients with severe COPD that received left internal mammary artery to left anterior descending artery (LAD) revascularization. All three patients were discharged on the first post-operative day with nil complications. All three patients were well at 3 months follow-up, having returned to their normal daily routine by 3 weeks with normal wound healing and without hospital readmission. Therefore, Mini OPCAB as a minimally invasive approach seems an attractive and feasible option in severe COPD, particularly those requiring revascularization to single vessel (LAD). This is the first documented report of Mini OPCAB performed successfully in patients with severe COPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.